August 3, 2016
(Medscape) – Demoralization is becoming increasingly recognized in the palliative care setting as a clinical problem that requires assessment and treatment. Prevalence rates range from 13% to 18% in patients with progressive diseases such as cancer. Defined as a “maladaptive coping response conceptualized as a loss of meaning and purpose, with feelings of hopelessness and helplessness,” the phenomenon can be treated, say researchers who report the refinement of a tool to measure demoralization.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.